Lobbyist information

Amount

Ed Coppinger

$44,000.00

Employed Terminated Details about your lobbyist or lobbyist entity's efforts 01/01/2026 Any and all legislation, regulations and policies pertaining to the healthcare system before the legislature or executive branch, including the Offices of the Governor and Lt Governor and all executive offices and agencies of the Commonwealth, the Office of the Attorney General, the Center for Health Information and Analysis, the Health Policy Commission, the Office of Pharmaceutical Policy and Analysis, and the Massachusetts Life Sciences Center, and that concern (a) a biopharmaceutical company's ability to market or sell its products in all sectors and markets in the Commonwealth; (b) patient access to innovative medicines and therapies in the Commonwealth; (c) implementation of Chapter 224 the Acts of 2012 as amended; (d) health care insurance coverage; (e) drug research and development; (f) pharmaceutical recycling, disposal and green bio policies; (g) drug pricing and drug price transparency; (h) the prescribing, dispensing and monitoring of controlled substances; (i) matters before the Massachusetts Life Sciences Center; (j) taxation policies affecting the biopharmaceutical industry; (k) drug safety policies; (j) pharmacy benefit manager practices; (k) the federal 340B program; (l) MassHealth coverage and reimbursement policies; and (m) drug marketing and marketing expense disclosure policies.

Kendalle Burlin O'Connell

$20,000.00

Employed Terminated Details about your lobbyist or lobbyist entity's efforts 01/01/2026 Any and all legislation, regulations and policies pertaining to the healthcare system before the legislature or executive branch, including the Offices of the Governor and Lt Governor and all executive offices and agencies of the Commonwealth, the Office of the Attorney General, the Center for Health Information and Analysis, the Health Policy Commission, the Office of Pharmaceutical Policy and Analysis, and the Massachusetts Life Sciences Center, and that concern (a) a biopharmaceutical company's ability to market or sell its products in all sectors and markets in the Commonwealth; (b) patient access to innovative medicines and therapies in the Commonwealth; (c) implementation of Chapter 224 the Acts of 2012 as amended; (d) health care insurance coverage; (e) drug research and development; (f) pharmaceutical recycling, disposal and green bio policies; (g) drug pricing and drug price transparency; (h) the prescribing, dispensing and monitoring of controlled substances; (i) matters before the Massachusetts Life Sciences Center; (j) taxation policies affecting the biopharmaceutical industry; (k) drug safety policies; (j) pharmacy benefit manager practices; (k) the federal 340B program; (l) MassHealth coverage and reimbursement policies; and (m) drug marketing and marketing expense disclosure policies.

Patrick Brown

$12,000.00

Employed Terminated Details about your lobbyist or lobbyist entity's efforts 01/01/2026 Any and all legislation and regulations pertaining to the healthcare system; Any issue that impacts a biopharmaceutical company's ability to market or sell its products in all sectors and markets in the Commonwealth; any policy or proposal that seeks to limit or restrict unfettered patient access to innovative medicines and therapies in the Commonwealth; implementation of Chapter 224 the Acts of 2012, health care reform, drug innovation, pharmaceuticals, recycling and disposal policies, provider and industry practices related to pharmaceuticals, drug pricing, drug transparency, prescribing, dispensing and monitoring controlled substances and related policies, patient access and prescribing related policies, research and development, taxation policies, drug safety, recycling and disposal policies green bio policies. Any and all legislation, regulation, policy matters before the legislature and related matters to the Office of the Attorney General, Center for Health Information and Analysis and the Health Policy Commission.

Susan Martin

$12,000.00

Employed Terminated Details about your lobbyist or lobbyist entity's efforts 01/01/2026 Any and all legislation, regulations and policies pertaining to the healthcare system before the legislature or executive branch, including the Offices of the Governor and Lt Governor and all executive offices and agencies of the Commonwealth, the Office of the Attorney General, the Center for Health Information and Analysis, the Health Policy Commission, the Office of Pharmaceutical Policy and Analysis, and the Massachusetts Life Sciences Center, and that concern (a) a biopharmaceutical company's ability to market or sell its products in all sectors and markets in the Commonwealth; (b) patient access to innovative medicines and therapies in the Commonwealth; (c) implementation of Chapter 224 the Acts of 2012 as amended; (d) health care insurance coverage; (e) drug research and development; (f) pharmaceutical recycling, disposal and green bio policies; (g) drug pricing and drug price transparency; (h) the prescribing, dispensing and monitoring of controlled substances; (i) matters before the Massachusetts Life Sciences Center; (j) taxation policies affecting the biopharmaceutical industry; (k) drug safety policies; (j) pharmacy benefit manager practices; (k) the federal 340B program; (l) MassHealth coverage and reimbursement policies; and (m) drug marketing and marketing expense disclosure policies.

Total salaries paid:      $88,000.00

Lobbyist Entity information

Amount

Commonwealth Counsel, LLC	$45,000.00
Employed Terminated 01/01/2026

Manatt, Phelps & Phillips LLP	$90,000.00
Employed Terminated 01/01/2026

Park Street Strategies, LLC	$60,000.00
Employed Terminated 01/01/2026

Smith Costello & Crawford Public Policy Group, LLC	$60,000.00
Employed Terminated 01/01/2026

Total salaries paid:      $255,000.00

Expenditures

Amount